Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge

- A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.) and Boehringer Ingelheim, will have to ask the Delaware Supreme Court directly for permission to appeal. GSK said it already submitted its appeal to that court.

GSK in a statement said"the scientific consensus remains that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer." Ranitidine is the active ingredient in the now discontinued drug. Medinilla wrote on Monday that she had not adopted a different standard from the Florida federal judge, but simply reached a different conclusion about the evidence in the case.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins bigDrugmakers released cancer data at ASCO, with AstraZeneca taking center stage. A report found that digital physical therapy tools provide clinical benefits.
Source: nbcsandiego - 🏆 524. / 51 Read more »

Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins bigDrugmakers released cancer data at ASCO, with AstraZeneca taking center stage. A report found that digital physical therapy tools provide clinical benefits.
Source: NBCNewYork - 🏆 270. / 63 Read more »